Wolf Peter
From Bioblast
Name | Wolf Peter, Dr.
Chief Scientific Officer (CSO) and Head of Assay Development |
---|---|
Institution | INCYTON GmbH,
Innovation and Start-Up Center for Biotechnology |
Address | Am Klopferspitz19A, 82152 |
City | Planegg/Martinsried |
State/Province | |
Country | Germany |
[email protected] | |
Weblink | https://www.incyton.com/ |
O2k-Network Lab |
Labels:
Publications
Published | Reference | |
---|---|---|
Heichler 2022 MitoFit | 2022 | Heichler C, Nagy M, Wolf P (2022) Evaluation of hepatotoxic effects of acetaminophen on HepG2 cells by parallel real-time monitoring in a multi-sensor analysis platform for automated cell-based assays. https://doi.org/10.26124/mitofit:2022-0006 β 2022-07-06 published in Bioenerg Commun 2022.6. |
Heichler 2022 BEC | 2022 | Heichler C, Nagy M, Wolf P (2022) Evaluation of hepatotoxic effects of acetaminophen on HepG2 cells by parallel real-time monitoring in a multi-sensor analysis platform for automated cell-based assays. Bioenerg Commun 2022.6. https://doi.org/10.26124/bec:2022-0006 |
Abstracts
Published | Reference | |
---|---|---|
Wolf 2022 Abstract Bioblast | 2022 | 5.4. Β«10+5Β» Heichler C, Nagy M, Wolf Peter (2022) Physiometabolic RTCA on an automated platform for short and long term applications. Bioblast 2022: BEC Inaugural Conference. In: https://doi.org/10.26124/bec:2022-0001 Β»Bioenergetics CommunicationsΒ« |